JP2023525981A5 - - Google Patents
Info
- Publication number
- JP2023525981A5 JP2023525981A5 JP2022566063A JP2022566063A JP2023525981A5 JP 2023525981 A5 JP2023525981 A5 JP 2023525981A5 JP 2022566063 A JP2022566063 A JP 2022566063A JP 2022566063 A JP2022566063 A JP 2022566063A JP 2023525981 A5 JP2023525981 A5 JP 2023525981A5
- Authority
- JP
- Japan
- Prior art keywords
- lung
- dione
- item
- pharmaceutically acceptable
- ethoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20382356 | 2020-04-30 | ||
| EP20382356.2 | 2020-04-30 | ||
| PCT/IB2021/053651 WO2021220250A1 (en) | 2020-04-30 | 2021-04-30 | Leriglitazone for treating lung inflammation and interstitial lung disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023525981A JP2023525981A (ja) | 2023-06-20 |
| JP2023525981A5 true JP2023525981A5 (cg-RX-API-DMAC7.html) | 2024-05-10 |
Family
ID=70779625
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022566063A Pending JP2023525981A (ja) | 2020-04-30 | 2021-04-30 | 肺炎症および間質性肺疾患を処置するためのレリグリタゾン |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230172921A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4142720A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023525981A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230035522A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116390725A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021265345A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022021951A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3180351A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL297771A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022013021A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021220250A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2020013181A (es) | 2018-06-06 | 2021-02-26 | Minoryx Therapeutics S L | Metodo para administrar una cantidad terapeuticamente efectiva de 5-[[4-[2-[5-(1-hidroxietil)piridin-2-il]etoxi]fenil]metil]-1,3-th iazolidin-2,4-diona. |
| JP2026500743A (ja) * | 2022-12-28 | 2026-01-08 | ミノリックス セラピューティクス エセ.エレ. | レリグリタゾンの最適投薬 |
| WO2024231881A2 (en) * | 2023-05-09 | 2024-11-14 | Minoryx Therapeutics S.L. | Polymorphic forms and formulations of leriglitazone |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2222272B1 (en) * | 2008-08-07 | 2012-11-07 | Pulmagen Therapeutics (Inflammation) Limited | Respiratory disease treatment |
| WO2010150014A1 (en) * | 2009-06-24 | 2010-12-29 | Pulmagen Therapeutics (Inflammation) Limited | 5r- 5 -deuterated glitazones for respiratory disease treatment |
| US20120190637A1 (en) * | 2009-10-14 | 2012-07-26 | Gemmus Pharma, Inc. | Combination therapy treatment for viral infections |
| WO2011073662A1 (en) * | 2009-12-17 | 2011-06-23 | Astrazeneca Ab | Combination of a benzoxazinone and a further agent for treating respiratory diseases |
| NZ725492A (en) | 2014-04-02 | 2023-06-30 | Minoryx Therapeutics S L | 2,4-thiazolidinedione derivatives in the treatment of central nervous system disorders |
| MX379710B (es) * | 2016-12-01 | 2025-03-11 | Minoryx Therapeutics S L | 5-[[4-[2-[5-(1-hidroxietil)piridin-2-il]etoxi]fenil]metil]]-1,3-tiazolidin-2,4-diona para el tratamiento de enfermedad de higado graso no alcoholico. |
| MX2020013182A (es) * | 2018-06-06 | 2021-02-26 | Minoryx Therapeutics S L | Uso de 5-[[4-[2-[5-acetilpiridin-2-il]etoxi]bencil]-1,3-tiazolidin a-2,4-diona y sus sales. |
-
2021
- 2021-04-30 CN CN202180043546.3A patent/CN116390725A/zh active Pending
- 2021-04-30 WO PCT/IB2021/053651 patent/WO2021220250A1/en not_active Ceased
- 2021-04-30 US US17/997,393 patent/US20230172921A1/en not_active Abandoned
- 2021-04-30 AU AU2021265345A patent/AU2021265345A1/en not_active Abandoned
- 2021-04-30 MX MX2022013021A patent/MX2022013021A/es unknown
- 2021-04-30 JP JP2022566063A patent/JP2023525981A/ja active Pending
- 2021-04-30 KR KR1020227042096A patent/KR20230035522A/ko not_active Abandoned
- 2021-04-30 BR BR112022021951A patent/BR112022021951A2/pt not_active IP Right Cessation
- 2021-04-30 IL IL297771A patent/IL297771A/en unknown
- 2021-04-30 CA CA3180351A patent/CA3180351A1/en active Pending
- 2021-04-30 EP EP21723015.0A patent/EP4142720A1/en not_active Withdrawn